The Korean Influenza National Immunization Program: History and Present Status
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
The Korean influenza national immunization program was first established as an interim program in 1997, administering the influenza vaccine to low-income elderly adults. In 2005, the program assumed its present form of providing free influenza vaccination to adults aged ≥65 years. After turning over the influenza vaccination for elderly adults to the private sectors in 2015, the influenza vaccination coverage rate among this population increased to >80%. In addition, after the 2009 H1N1 influenza epidemic crisis, the vaccine was domestically produced. By reaching a 75% vaccination coverage rate in the target groups, it was possible to put an end to the influenza pandemic and fix the shortcomings of the system that existed at that time. The influenza vaccination program, provided free of cost, was extended to include infants aged <12 months in 2016 and ≤59 months in 2017 in order to reduce the influenza burden in these populations. However, the vaccine effectiveness remains low despite the high vaccination rates in elderly adults. Therefore, several areas, such as the adoption of quadrivalent influenza vaccine, adjuvanted influenza vaccine, and high-dose influenza vaccine and the expansion of vaccination target groups, still need to be addressed.
Abstract
The Korean influenza national immunization program was first established as an interim program in 1997, administering the influenza vaccine to low-income elderly adults. In 2005, the program assumed its present form of providing free influenza vaccination to adults aged ≥65 years. After turning over the influenza vaccination for elderly adults to the private sectors in 2015, the influenza vaccination coverage rate among this population increased to >80%. In addition, after the 2009 H1N1 influenza epidemic crisis, the vaccine was domestically produced. By reaching a 75% vaccination coverage rate in the target groups, it was possible to put an end to the influenza pandemic and fix the shortcomings of the system that existed at that time. The influenza vaccination program, provided free of cost, was extended to include infants aged <12 months in 2016 and ≤59 months in 2017 in order to reduce the influenza burden in these populations. However, the vaccine effectiveness remains low despite the high vaccination rates in elderly adults. Therefore, several areas, such as the adoption of quadrivalent influenza vaccine, adjuvanted influenza vaccine, and high-dose influenza vaccine and the expansion of vaccination target groups, still need to be addressed.
참고문헌 (28)
- Immunization Target Infectious Disease Epidemiology and Management Guidelines Ch 21. Influenza, "Korean Centre for Disease Control and Prevention (KCDC)", Korean Centre for Disease Control and Prevention, 435~462 (2017)
- "Health at a glance 2015"[URL]
- Korean National Institute of Health (KNIH), "‘02–’03 Influenza Management Guidelines" (2002), KNIH
- Korean National Institute of Health (KNIH), "‘03–’04 Influenza Management Guidelines" (2003), KNIH
- Korean Centre for Disease Control and Prevention (KCDC), "2004–2005 Influenza Management Guidelines" (2004), KCDC
- Korean Centre for Disease Control and Prevention (KCDC), "2005–2006 Influenza Management Guidelines" (2005), KCDC
- Korean Centre for Disease Control and Prevention (KCDC), "2006–2007 Influenza Management Guidelines" (2006), KCDC
- Korean Centre for Disease Control and Prevention (KCDC), "2007–2008 Influenza Management Guidelines" (2007), KCDC
- Korean Centre for Disease Control and Prevention (KCDC), "2008–2009 Influenza Management Guidelines" (2008), KCDC
- Korean Centre for Disease Control and Prevention (KCDC), "2010–2011 Influenza Management Guidelines" (2010), KCDC
- "2011–2012 Influenza management guidelines"[URL]
- "2012–2013 Influenza management guidelines"[URL]
- "2013–2014 Influenza management guidelines"[URL]
- "2014–2015 Influenza management guidelines"[URL]
- "2015-2016 Influenza management guidelines"[URL]
- "2016-2017 Influenza management guidelines"[URL]
- "2017-2018 Influenza management guidelines"[URL]
- White paper on disease management, "Korean Centre for Disease Control and Prevention (KCDC)", KCDC, 131~133 (2013)
- 2009-2010 Seasonal influenza immunization plan, "Korean Centre for Disease Control and Prevention (KCDC)", KCDC, ~ (2009)
- Reported adverse events following seasonal influenza and 2009 influenza A (H1N1), "Korean Centre for Disease Control and Prevention (KCDC)", KCDC, ~ (2017)
- "Adverse reactions guidelines for immunization"[URL]
- "Newsletter of national immunization program: 2014-2017"[URL]
- Kim WJ, "Incidence of narcolepsy before and after MF59-adjuvanted influenza A (H1N1) pdm09 vaccination in South Korean soldiers", Vaccine, 33, pp.4868~4872 (2015)
- White paper on Health and Welfare, "Korean Centre for Disease Control and Prevention (KCDC)", KCDC, 501~513 (2013)
- 2009 Influenza A (H1N1) response report, "Korean Centre for Disease Control and Prevention (KCDC)", KCDC, ~ (2010)
- Korean Centre for Disease Control and Prevention (KCDC), "2009-2010 Influenza A (H1N1) vaccination program in Korea", Public Health Weekly Report, 3, pp.357~360 (2010)
- Goodwin K, "Antibody response to influenza vaccination in the elderly: a quantitative review", Vaccine, 24, pp.1159~1169 (2006)
- Park M, "Influenza- associated excess mortality in South Korea", Am J Prev Med, 50, pp.e111~e119 (2016)